<DOC>
	<DOCNO>NCT02305368</DOCNO>
	<brief_summary>In patient colonic adenocarcinoma stage 4 potentially resectable metastasis ( lung liver metastasis ) , treatment chemotherapy necessary end success 10 % case . The development technique administer personalized treatment becomes necessary patient . Thus , vitro test cell tumor patient evaluate effect chemotherapy could make patient . In France , company develop Oncomedics test . This pilot study make first evaluation actual condition chimio-oncogramme .</brief_summary>
	<brief_title>Evaluation Interest Chemo-oncogramme Patients With Colonic Adenocarcinoma Stage 4</brief_title>
	<detailed_description>A fragment colon tumor take specimen cold biopsy , tissue patient diagnose colon carcinoma metastatic ( stage 4 ) . In parallel systematically : analysis pathologist histological section . - Culturing cell obtain tumor Oncomedics fragment define medium provide enrich tumor cell compare stromal cell . - Maintaining cell culture 7 day . - Effects conventional chemotherapy ( correspond protocol ) cell 72 hour ( growth chamber ) Oncomedics ( chimio-oncogramme ) . - For chemotherapy test , measure proportion dead cell / total cell . - Retained Oncomedics result , give nursing team . The patient treat follow usual way . - At end study , compare vitro result ( chimio-oncogramme ) patient 's response ( x ) ( ) chemotherapy ( ) .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>patient adenocarcinoma colon diagnose stage 4 receive standard therapy target must measurable tumor lesion ( RECIST ) patient express opposition use residual tumor Againstformal indication indispensable paraclinical examination patient monitoring Use chemotherapy , hormone therapy concomitant radiotherapy Consindication chemotherapy Are pregnant , nursing lack contraception woman childbearing age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>